Masonic Cancer Center, University of Minnesota: Breast Neoplasms trials
The registry lists 16 Breast Neoplasms studies with Masonic Cancer Center, University of Minnesota as lead sponsor. 0 are open to participants now and 6 have results posted.
Phase 1 5Phase 2 8No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Assessing the Time Demands of CancerActive, not recruitingNCT05708703Results posted
- Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast CancerCompletedNCT01105650Phase 2Results posted
- Enalapril Maleate and Doxorubicin Hydrochloride in Treating Women With Breast CancerCompletedNCT00895414Not applicableResults posted
- Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast CaTerminatedNCT00784524Phase 2Results posted
- Phase II of Naltrexone in Hormone-Refractory Metastatic Breast CancerTerminatedNCT00379197Phase 2Results posted
- Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast CancerTerminatedNCT00376805Phase 2Results posted
- Physical Rehabilitation Evaluation and Optimal Physical Therapy (PRE-OPT)CompletedNCT04225572Not applicable
- Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast CancerCompletedNCT03981705
- BAriaTric Surgery After Breast Cancer Treatment (BATS)WithdrawnNCT03946423Not applicable
- Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast CancerCompletedNCT01009437Phase 1
- Everolimus in Treating Women With Breast Cancer That Can Be Removed by SurgeryWithdrawnNCT00855114Phase 2
- Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone MetastasesWithdrawnNCT00769990Phase 1/2
- Clinical Trial of Trametes Versicolor in Women With Breast CancerCompletedNCT00680667Phase 1
- MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast CancerWithdrawnNCT00373152Phase 2
- Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney CancerCompletedNCT00365287Phase 1/2
- Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast CancerTerminatedNCT00005993Phase 1